MARSHALL WACE, LLP - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACW and the CUSIP is G3167F128. A total of 32 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q4 2022$364,165
-66.2%
36,056
-66.8%
0.00%
-50.0%
Q3 2022$1,076,000
+1.3%
108,5840.0%0.00%0.0%
Q2 2022$1,062,000
-0.3%
108,5840.0%0.00%0.0%
Q1 2022$1,065,000
+0.9%
108,5840.0%0.00%0.0%
Q4 2021$1,056,000
-0.1%
108,5840.0%0.00%
-50.0%
Q3 2021$1,057,000
+0.8%
108,5840.0%0.00%
-20.0%
Q2 2021$1,049,000108,5840.01%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q4 2021
NameSharesValueWeighting ↓
ANGELO GORDON & CO., L.P. 13,333$132,0000.02%
Radcliffe Capital Management, L.P. 66,666$661,0000.02%
MARSHALL WACE, LLP 108,584$1,076,0000.00%
MMCAP International Inc. SPC 73,525$7,0000.00%
DIFESA CAPITAL MANAGEMENT, LP 14,159$1,0000.00%
WHITEBOX ADVISORS LLC 16,833$2,0000.00%
MILLENNIUM MANAGEMENT LLC 140,000$14,0000.00%
LINDEN ADVISORS LP 40,115$3,0000.00%
Calamos Advisors LLC 33,333$2,0000.00%
STATE OF WISCONSIN INVESTMENT BOARD 19,560$1,0000.00%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders